Ana Mann joined Flagship in 2020 as assistant controller for Flagship Labs. In her role, Ana partners with Flagship portfolio companies to provide financial and operational oversight. She is responsible for financial reporting and forecasting to measure progress on company performance. She also assists with improving operational processes to better inform the business and drive the science. She is enthusiastic about Flagship’s commitment to helping patients and the potential impact that can be created within the portfolio companies.
Prior to Flagship, Ana served as accounting manager at Editas Medicine, a leading genome editing company. During her time at Editas Medicine, Ana had a wide variety of responsibilities including general ledger accounting, SEC reporting, and internal controls. She began her career in Deloitte’s advisory practice focusing on process improvement and internal audit within the healthcare and life science industry.
Ana holds a B.S. and M.S. in Accountancy from Louisiana State University and earned her C.P.A. in 2013.